Silvia Chang, Masters

Associate Scientist
Gilead Sciences

Disclosure: Gilead Sciences (Individual(s) Involved: Self): Employee, Shareholder

Presentation(s):

• 109 - preexisting Resistance and Week 48 Virologic Outcomes After Switching to B/F/TAF in African American Adults with Hiv

  Oral Abstract